Sven Ante Lundberg's Net Worth
$24.4 Million
Who is Sven Ante Lundberg?
Sven Ante Lundberg has an estimated net worth of $24.4 Million. This is based on reported shares across multiple companies, which include Merus N.V., Vor Biopharma Inc., CRISPR Therapeutics AG, and Homology Medicines, Inc..
SEC CIK
Sven Ante Lundberg's CIK is 0001682126
Past Insider Trading and Trends
2021 was Sven Ante Lundberg's most active year for acquiring shares with 6 total transactions. Sven Ante Lundberg's most active month to acquire stocks was the month of July. 2021 was Sven Ante Lundberg's most active year for disposing of shares, totalling 5 transactions. Sven Ante Lundberg's most active month to dispose stocks was the month of February. 2021 saw Sven Ante Lundberg paying a total of $1,190,341.06 for 473,900 shares, this is the most they've acquired in one year. In 2021 Sven Ante Lundberg cashed out on 163,000 shares for a total of $200,474.46, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merus N.V. (MRUS) Snapshot price: $50
President, CEO & PEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +56.85% | 14.71K |
$14.38 | $211,431.10 | 40.58K |
Nov 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +29.07% | 5.83K |
$22.92 | $133,558.14 | 25.87K |
Aug 22
| |||
Form 4
| +3.64% | 704 |
$22.99 | $16,186.93 | 20.04K |
Aug 19
| |||
Form 4
| +28.93% | 4.34K |
$22.97 | $99,684.59 | 19.34K |
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
∞
| 15K |
$13.36 | $200,474.46 | 15K |
Aug 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -74.00K |
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
∞
| 74K |
$13.38 | $989,866.60 | 74K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vor Biopharma Inc. (VOR) Snapshot price: $0.9001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.82% | 55.62K |
$14.00 | $5,600.00 | 1.01M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||